Jessica Fye
Stock Analyst at JP Morgan
(2.05)
# 963
Out of 5,328 analysts
224
Total ratings
57.80%
Success rate
9.13%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
UTHR United Therapeutics | Maintains: Overweight | 355 350 | 293.04 | 19.44% | 13 | May 1, 2025 | |
INCY Incyte | Maintains: Neutral | 70 68 | 62.2 | 9.32% | 6 | Apr 21, 2025 | |
HALO Halozyme Therapeutic... | Maintains: Neutral | 55 58 | 60.53 | -4.18% | 10 | Apr 21, 2025 | |
ONC BeiGene | Maintains: Overweight | 311 317 | 259.23 | 22.29% | 1 | Apr 21, 2025 | |
IMCR Immunocore Holdings | Maintains: Overweight | 54 50 | 30.05 | 66.39% | 5 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 29 28 | 18 | 55.56% | 4 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 47 45 | 31.99 | 40.67% | 4 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 280 328 | 252.64 | 29.83% | 5 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 40 33 | 27.43 | 20.31% | 12 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 168 200 | 166.36 | 20.22% | 10 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 200 209 | 117.34 | 78.11% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 83 92 | 72.8 | 26.37% | 7 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 24 | 16.09 | 49.16% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 503 500 | 500.59 | -0.12% | 7 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 124 122 | 103.03 | 18.41% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 81 89 | n/a | n/a | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 110 109 | 62.88 | 73.35% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 32 26 | 30.57 | -14.95% | 6 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 200 235 | n/a | n/a | 4 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | 11.25 | 166.67% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 47 54 | 33.62 | 60.62% | 5 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 39 | 43.63 | -10.61% | 3 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 13 | 9.87 | 31.71% | 4 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 16 | n/a | n/a | 5 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 25 45 | n/a | n/a | 4 | Dec 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 217 330 | n/a | n/a | 1 | Dec 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underweight | n/a | n/a | n/a | 7 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underweight | n/a | n/a | n/a | 2 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | n/a | n/a | n/a | 9 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underweight | n/a | n/a | n/a | 3 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 10 | 8.74 | 14.42% | 3 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | n/a | n/a | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 65 76 | 34.19 | 122.29% | 2 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 154 150 | n/a | n/a | 2 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 612 720 | n/a | n/a | 2 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 150 70 | n/a | n/a | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 256 112 | n/a | n/a | 2 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 3 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 22 | 1.24 | 1674.19% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 | 0.71 | 885.92% | 2 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 27 | 29.41 | -8.19% | 5 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 9 8 | n/a | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 8 | n/a | n/a | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 58 | n/a | n/a | 2 | Jan 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 3 | Feb 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Feb 14, 2018 |